By Abigail W. Adams
Portland, Me., Jan. 8 – Hansoh Pharmaceutical Group Co. Ltd. priced an upsized $600 million of five-year convertible notes on Thursday at par with a coupon of 0% and an initial conversion premium of 44%, according to a company announcement.
Price talk was for a fixed coupon of 0% and an initial conversion premium of 42.5% to 52.5%, according to a market source.
Citigroup Global Markets Ltd. was the bookrunner for the Regulation S offering.
The initial size of the offering was $500 million.
The bonds are non-callable until Jan. 22, 2024 and then subject to a 125% hurdle.
They are putable on Jan. 22, 2024 or upon a change-of-control or delisting event.
The bonds are convertible into shares that trade on the Hong Kong stock exchange at a fixed exchange rate of HK$7.7529 to US$1.00.
Proceeds will be used for research and development, construction of manufacturing facilities and general corporate purposes.
Hansoh Pharmaceutical Group is a Hong Kong-based pharmaceutical company.
Issuer: | Hansoh Pharmaceutical Group Co. Ltd.
|
Securities: | Convertible notes
|
Amount: | $600 million
|
Maturity: | Jan. 22, 2026
|
Bookrunner: | Citigroup Global Markets Ltd.
|
Coupon: | 0%
|
Price: | Par
|
Yield: | 0%
|
Conversion premium: | 44%
|
Conversion price: | HK$60
|
Call options: | Non-callable until Jan. 22, 2024 and then subject to a 125% hurdle
|
Put options: | Putable on Jan. 22, 2024 or upon a fundamental change
|
Pricing date: | Jan. 7
|
Settlement date: | Jan. 22
|
Distribution: | Regulation S
|
Talk: | Fixed coupon of 0% and initial conversion premium of 42.5% to 52.5%
|
Stock symbol: | HKG: 3692
|
Stock price: | HK$41.65 at market close Jan. 7
|
Market capitalization: | HK$235.28 billion
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.